Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Godrej Consumer Products reported a resilient Q2 FY26 with consolidated revenue growth of 4% and underlying volume growth of 3%, despite GST transition disruptions in India and macro challenges in Indonesia.
✓ Verified against BSE filing
Godrej Consumer Products reported a resilient Q2 FY26 with consolidated revenue growth of 4% and underlying volume growth of 3%, despite GST transition disruptions in India and macro challenges in Indonesia. India business (ex-soaps) delivered double-digit volume growth, while soaps faced a temporary hit from GST-related trade destocking. EBITDA margin stood at 19.3%, with net profit before exceptionals declining 2%. Management expects India margins to return to normative levels (24-26%) in H2, driven by cost savings and media efficiencies. Indonesia remains under pressure with low single-digit volume growth and negative pricing, but Africa posted strong 25% revenue growth. The acquisition of Muuchstac (men's face wash) at ~4x sales adds a high-growth, profitable brand. Key risks include prolonged weakness in Indonesia, currency volatility in Africa, and adverse winter season impacting household insecticides.
गोदरेज कंज्यूमर प्रोडक्ट्स ने दूसरी तिमाही में 4% की कमाई बढ़ोतरी दर्ज की, जबकि बिक्री में 3% की वृद्धि हुई। भारत में जीएसटी बदलाव और इंडोनेशिया में आर्थिक चुनौतियों के बावजूद कंपनी मजबूत रही। भारत में साबुन को छोड़कर बाकी उत्पादों की बिक्री दो अंकों में बढ़ी, लेकिन साबुन पर जीएसटी के कारण अस्थायी असर पड़ा। कंपनी का मुनाफा मार्जिन 19.3% रहा, जबकि शुद्ध लाभ में 2% की गिरावट आई। प्रबंधन को उम्मीद है कि साल की दूसरी छमाही में भारत का मार्जिन 24-26% तक पहुंच जाएगा। इंडोनेशिया में बिक्री धीमी रही, लेकिन अफ्रीका में 25% की जबरदस्त बढ़ोतरी हुई। मुचस्टैक (पुरुषों का फेस वॉश) खरीदने से कंपनी को फायदा होगा। मुख्य जोखिमों में इंडोनेशिया की कमजोरी, अफ्रीका में मुद्रा में उतार-चढ़ाव और सर्दियों का मौसम शामिल है।
0 delivered, 0 close, 1 missed.
View Promises →Prolonged weakness in Indonesia
View Risks →Full transcript text is available on this route.
Read Transcript →India business excluding soaps delivered double-digit volume growth, reflecting strength in core portfolio.
Africa, USA, and Middle East delivered 25% sales growth in INR terms, led by Hair Fashion and Air Fresheners.
Indonesia delivered stable UVG of 2% with market share gains, but revenue growth negative due to pricing pressures.
Godrej has become market leader in incense sticks, growing at roughly 100%.
Management expects India standalone business to achieve high single-digit underlying volume growth for the full year, driven by recovery in soaps and continued momentum in non-soap categories.
India standalone and GAUM businesses are expected to deliver double-digit EBITDA growth for the full year.
Management reiterated confidence in achieving high single-digit revenue growth at consolidated level for the full year.
Management expects India margins to return to normative levels (24-26%) in the second half of FY26, albeit at the lower end of the band.
Management expects double-digit consolidated EBITDA growth for FY26.
Underlying volume growth for standalone business expected to be mid-to-high single digit for the full year.
Indonesia faces macro slowdown and competitive pricing pressures, with volume growth expected to remain low single-digit for next few quarters.
Africa margins are subject to currency fluctuations; while currently favorable, volatility can impact profitability.
A harsh winter due to La Niña could reduce mosquito season, negatively impacting H2 sales of household insecticides.
The Muuchstac brand is currently online-focused; scaling to offline channels and maintaining profitability may pose challenges.
Indonesia business impacted by macro headwinds and competitive pricing; management expects transitory but uncertainty remains.
Grammage cuts and poor season led to soap volume decline; recovery depends on base effects and consumer behavior.
Palm oil prices have moderated but recently rallied 10%; benefits may be delayed if prices stay elevated.
Competitors may reverse-engineer new molecule or copy messaging, potentially reducing GCPL's differentiation.
Mentioned in Q2 FY25, Q3 FY25
Management targets India EBITDA margins in the 24-26% range, expecting to reach this level in the next 6-8 months.
Mentioned in Q2 FY25, Q3 FY25
Management noted a significant urban slowdown, with premium products and modern trade under pressure, which could persist and impact growth.
Management expects India standalone business to achieve high single-digit underlying volume growth for the full year, driven by recovery in soaps a...
Indonesia faces macro slowdown and competitive pricing pressures, with volume growth expected to remain low single-digit for next few quarters.
View Risks →